Services and information
Designing, developing and producing innovative biologics in Canada
Biologics are vaccines and therapeutics derived from living organisms or from their cells and are produced using advanced biotechnology processes. With our multidisciplinary expertise, we design, develop and test novel biologics to treat Canadians and to prevent them from getting sick in the first place.
We develop biologics for complex health challenges, such as emerging infections, cancer and neurological diseases.
We use our expertise to improve the production process for complex biologics.
We collaborate to advance personalized and off-the-shelf biologics, such as cell and gene therapies.
Multidisciplinary expertise in biologics development
With one of the largest research and development teams dedicated to biologics development in Canada, we collaborate with industry, hospitals, health networks, academia and government to advance novel biologics. Our technical expertise, advisory services and leading-edge facilities span the biologics development process—from discovery to clinical material production.
Generate high-potential candidates with our proprietary cell lines, multifunctional antibodies, vectors and adjuvants.
Evaluate biologic candidates with our small-scale manufacturing capabilities and in vivo and in vitro testing expertise.
Improve bioprocesses with our expertise and R&D labs for in-process scale-up, analytics, modelling and intensification.
Optimize bioprocesses in compliance with good manufacturing practices (GMP) and produce biologics at clinical scale in our specialized facility.